Implant Sciences Receives Initial Order for Sale of Explosives Detection Equipment in Lebanon(WAKEFIELD, Mass., Dec. 7, 2005) -- Implant Sciences Corporation (AMEX: "IMX", "IMX.WS") a developer and manufacturer of products for national security, medicine and industry, today announced the receipt of a purchase order for fifty (50) Quantum Sniffer(TM) explosives detectors from Homeland Integrated Security Systems, Inc. (Pink Sheets: "HISC"), the Company's exclusive distributor of explosives detection equipment in Lebanon. This purchase order provides for an initial shipment of twenty (20) units to HISC in the Company's third quarter of fiscal 2006, which will begin January 1, 2006, for which an advance payment equal to thirty percent (30%) of the purchase price has been received. Upon shipment of the initial twenty (20) units, the purchase order provides for the production of the remaining thirty (30) units and shipment to HISC in the Company's fourth quarter of fiscal 2006. We understand that the initial shipment of Quantum Sniffers will be sold to a leading Lebanese security company for the security and protection of commercial buildings, such as hotels, and government installations.
Dr. Anthony J. Armini, PhD., CEO of Implant Sciences, commented, "Over the past several months our efforts in promoting and raising the level of awareness of our Quantum Sniffer explosives detection equipment in Europe, the Middle East, Asia and Australia have met with continued success as evidenced by the increasing number of orders. We believe this large order placed by Homeland Integrated Security Systems for their Middle East customer is the result of months of hard work by their sales team in demonstrating the technological benefits of the Quantum Sniffer explosives detection equipment as compared to the competition. We are gratified at HISC's commitment to making the placement of the Quantum Sniffer explosives detection equipment a top priority in their sales efforts."
The Global Counter IED Market 2012-2022
About Implant Sciences
Implant Sciences, incorporated in 1984, is using its core ion technology to develop, manufacture and market products for the homeland security, semiconductor and medical device industries. The Company has developed and commercialized portable and bench-top detection devices to identify explosives which are distributed under the Quantum Sniffer(TM) brand name. The Company also provides state of the art ion implantation and wafer analytical services for the semiconductor industry. The Company also develops, manufactures and sells radioactive products for the treatment of cancer, including sales of radioactive seeds for the treatment of prostate cancer and development of a new, FDA approved radioactive source for use in the treatment of breast cancer. For further details on the Company and its products please visit the Company's website at www.implantsciences.com.
About Homeland Integrated Security Systems, Inc.
Homeland Integrated Security Systems owns proprietary technology and patent rights to innovative and sophisticated security products for national and international security and industry. Among the key target markets are the 361 commercial seaports in the U.S. which are vulnerable to criminal penetration. The Company is now accepting pre-orders for the Cyber Tracker at www.hissusa.com.
Implant Sciences believes that this release contains forward-looking statements that are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to facts that could cause results to differ materially from the forward-looking statements. For further information you are encouraged to review Implant Sciences' filings with the Securities and Exchange Commission.
508-523-3141 or 781-246-0700, ext. 105
Source : Implant Sciences Corporation